<html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta http-equiv="Content-Style-Type" content="text/css" /><meta name="generator" content="Aspose.Words for .NET 13.4.0.0" /><title>Tri radioj batos kvar</title></head><body><div><p style="margin:0pt"><span style="color:#052754; font-family:Arial; font-size:9pt">&#xa0;</span></p><p style="margin:0pt 7.1pt 0pt 0pt; text-align:center"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">Written evidence submitted by the Society of Biology (RaD0008)</span></p><p style="font-size:11pt; line-height:115%; margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="font-size:11pt; line-height:115%; margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">The Society of Biology</span><span style="font-family:'Times New Roman'; font-size:11pt"> welcomes the Committee’s attention to </span><span style="font-family:'Times New Roman'; font-size:11pt">research and </span><span style="font-family:'Times New Roman'; font-size:11pt">development</span><span style="font-family:'Times New Roman'; font-size:11pt"> fund</span><span style="font-family:'Times New Roman'; font-size:11pt">ing for science and technology; a core sector that</span><span style="font-family:'Times New Roman'; font-size:11pt"> underpins the UK’s economic stability through n</span><span style="font-family:'Times New Roman'; font-size:11pt">ovel products and job creation, and is pleased to have sight of the detailed analysis in the National Audit Office memorandum on this topic. </span></p><p style="font-size:11pt; line-height:115%; margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="font-size:11pt; line-height:115%; margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">The NAO</span><span style="font-family:'Times New Roman'; font-size:11pt"> memorandum confirms</span><span style="font-family:'Times New Roman'; font-size:11pt"> the value of R&amp;D carried out by UK business, where the life science</span><span style="font-family:'Times New Roman'; font-size:11pt">s play a major role and</span><span style="font-family:'Times New Roman'; font-size:11pt"> biotechnolo</span><span style="font-family:'Times New Roman'; font-size:11pt">gy and pharmaceutical companies are </span><span style="font-family:'Times New Roman'; font-size:11pt">the dominating sectors. </span><span style="font-family:'Times New Roman'; font-size:11pt">The UK business R</span><span style="font-family:'Times New Roman'; font-size:11pt">&amp;</span><span style="font-family:'Times New Roman'; font-size:11pt">D spend, for which tax incentives are so import</span><span style="font-family:'Times New Roman'; font-size:11pt">ant, is bolstered by our particular strengths in </span><span style="font-family:'Times New Roman'; font-size:11pt">life sciences, </span><span style="font-family:'Times New Roman'; font-size:11pt">software, </span><span style="font-family:'Times New Roman'; font-size:11pt">and </span><span style="font-family:'Times New Roman'; font-size:11pt">advanced engineering research </span><span style="font-family:'Times New Roman'; font-size:11pt">that</span><span style="font-family:'Times New Roman'; font-size:11pt"> attract </span><span style="font-family:'Times New Roman'; font-size:11pt">substantial</span><span style="font-family:'Times New Roman'; font-size:11pt"> Foreign Direct Investment</span><a name="_ftnref1"></a><a href="#_ftn1">[1]</a><span style="font-family:'Times New Roman'; font-size:11pt">. The UK’s talent and attractive research environment is strengthened </span><span style="font-family:'Times New Roman'; font-size:11pt">by </span><span style="font-family:'Times New Roman'; font-size:11pt">BIS</span><span style="font-family:'Times New Roman'; font-size:11pt">’s commitment</span><span style="font-family:'Times New Roman'; font-size:11pt"> to improve the interface betwee</span><span style="font-family:'Times New Roman'; font-size:11pt">n Higher Education Institutions </span><span style="font-family:'Times New Roman'; font-size:11pt">and businesses, and supportive statements by </span><span style="font-family:'Times New Roman'; font-size:11pt">G</span><span style="font-family:'Times New Roman'; font-size:11pt">overnment that </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">'investment in science is an investment in our future</span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">’</span><a name="_ftnref2"></a><a href="#_ftn2">[2]</a><span style="font-family:'Times New Roman'; font-size:11pt">.</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span></p><p style="font-size:11pt; line-height:115%; margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="font-size:11pt; line-height:115%; margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">At both the 2010 and 2013 spending reviews</span><span style="font-family:'Times New Roman'; font-size:11pt">, Government </span><span style="font-family:'Times New Roman'; font-size:11pt">recognised the sustained excellence of the science sector with a </span><span style="font-family:'Times New Roman'; font-size:11pt">flat</span><span style="font-family:'Times New Roman'; font-size:11pt"> cash </span><span style="font-family:'Times New Roman'; font-size:11pt">settlement for the resource budget. Although we welcomed the ring fence, </span><span style="font-family:'Times New Roman'; font-size:11pt">we note that </span><span style="font-family:'Times New Roman'; font-size:11pt">if the Government want</span><span style="font-family:'Times New Roman'; font-size:11pt">s a growth economy, it must support a sector that employs more than </span><span style="font-family:'Times New Roman'; font-size:11pt">5.4m </span><span style="font-family:'Times New Roman'; font-size:11pt">UK workers</span><a name="_ftnref3"></a><a href="#_ftn3">[3]</a><span style="font-family:'Times New Roman'; font-size:11pt"> and provides </span><span style="font-family:'Times New Roman'; font-size:11pt">an impressive return on investment.</span><span style="font-family:'Times New Roman'; font-size:11pt"> A</span><span style="font-family:'Times New Roman'; font-size:11pt">bove inflation growth in the science budget is </span><span style="font-family:'Times New Roman'; font-size:11pt">therefore </span><span style="font-family:'Times New Roman'; font-size:11pt">needed if the sciences are to deliver their full potential for improving the economy and wellbeing. It is essential that the virtual cuts</span><span style="font-family:'Times New Roman'; font-size:11pt"> in the science budget are reversed if the research community is to deliver the full benefit the country needs.</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span></p><p style="font-size:11pt; line-height:115%; margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="font-size:11pt; line-height:115%; margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">The UK is currently the number one in Europe in terms of Foreign Direct Investment, but maintaining our i</span><span style="font-family:'Times New Roman'; font-size:11pt">nternational competitively is crucial, </span><span style="font-family:'Times New Roman'; font-size:11pt">particularly</span><span style="font-family:'Times New Roman'; font-size:11pt"> as the global economy changes </span><span style="font-family:'Times New Roman'; font-size:11pt">and</span><span style="font-family:'Times New Roman'; font-size:11pt"> BRIC </span><span style="font-family:'Times New Roman'; font-size:11pt">nations advance. </span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">The NAO memorandum clearly shows that the UK is falling behind on</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">R&amp;D intensity at just 1.9%, way off the 3% target for </span><span style="font-family:'Times New Roman'; font-size:11pt">the European Commission by </span><span style="font-family:'Times New Roman'; font-size:11pt">2020.  </span><span style="font-family:'Times New Roman'; font-size:11pt">The UK’s failure to </span><span style="font-family:'Times New Roman'; font-size:11pt">aim for</span><span style="font-family:'Times New Roman'; font-size:11pt"> this target is concerning and contradictory to Government rhetoric on the importance of the UK science sector.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="font-size:11pt; line-height:115%; margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Government Departments have a key role in funding research outside of public labs, and should be seen as an i</span><span style="font-family:'Times New Roman'; font-size:11pt">ntegral part of the UK’s research ecosystem.  This area of funding has been severely hit by recent cuts, creating concern about training, skills development and policy- relevant research across the sciences. These budgets should also be taken into consider</span><span style="font-family:'Times New Roman'; font-size:11pt">ation when investigating the resilience of the UK science sector. </span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic; font-weight:bold">&#xa0;</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic; font-weight:bold">Public Sector Research Establishments</span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic; font-weight:bold"> </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic; font-weight:bold">(PSREs)</span></p><p style="font-size:11pt; line-height:115%; margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Certain PRSEs carry out a range of vital services across the life sciences, and provide essential expertise for increasingly complex and </span><span style="font-family:'Times New Roman'; font-size:11pt">relevant policy issues including human health, the agriculture sector and sustainable food provision, the green economy and national safety:</span></p><h1 style="font-size:11pt; line-height:115%; margin:5pt 0pt 5pt 50.25pt; text-align:justify; text-indent:-18pt"><span style="font-family:Symbol; font-size:11pt; font-weight:bold"></span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">Public Health England’s major role is to improve the nation’s hea</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">lth and to address inequalities</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">, including disease</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal"> surveillance, emergency response and public health strategy</span><a name="_ftnref4"></a><a href="#_ftn4">[4]</a><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">;</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal"> </span></h1><h1 style="font-size:11pt; line-height:115%; margin:5pt 0pt 5pt 50.25pt; text-align:justify; text-indent:-18pt"><span style="font-family:Symbol; font-size:11pt; font-weight:bold"></span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">Forest Research </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">has a key role in forest management, including </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">for economic benefit and conservation and </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">control of </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">damaging pests such as </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">Ash Dieback and Oak processiona</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">ry moth,</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal"> and ensuring capacity to deal with emerging problems;</span></h1><h1 style="font-size:11pt; line-height:115%; margin:5pt 0pt 5pt 50.25pt; text-align:justify; text-indent:-18pt"><span style="font-family:Symbol; font-size:11pt; font-weight:bold"></span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">The Veterinary Medicines Directorate is </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">responsible for the</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal"> safe and effective use of veterinary medicinal products to the benefit of agriculture, wildlife and domestic animals;</span></h1><h1 style="font-size:11pt; line-height:115%; margin:5pt 0pt 5pt 50.25pt; text-align:justify; text-indent:-18pt"><span style="font-family:Symbol; font-size:11pt; font-weight:bold"></span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">The Centre for Environment, Fisheries </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">&amp;</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal"> Aquaculture shapes policy in the fisheries sector, researching marine ecosystems and food security, </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">helping to mitigate damage from marine accidents </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">and advising industry;</span></h1><h1 style="font-size:11pt; line-height:115%; margin:5pt 0pt 5pt 50.25pt; text-align:justify; text-indent:-18pt"><span style="font-family:Symbol; font-size:11pt; font-weight:bold"></span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">Fera focusses </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">on developing</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal"> a sustainable fo</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">od chain, and protecting against biological and chemical risks;</span></h1><h1 style="font-size:11pt; line-height:115%; margin:5pt 0pt 5pt 50.25pt; text-align:justify; text-indent:-18pt"><span style="font-family:Symbol; font-size:11pt; font-weight:bold"></span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">Finally, the Defence Science &amp; Technology Laboratory holds a wealth of expertise, working with</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal"> a range</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal"> of institutions in and out of G</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">overnment to maximise the impact of science and technology</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal"> on UK defence and security. </span></h1><h1 style="font-size:11pt; line-height:115%; margin:5pt 0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">Clearly these PSREs are an important part of the UK’s research ecology, </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">acting</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal"> as hubs of expertise that foster the development of skills and training</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">,</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal"> and are at the </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">frontline of applied research </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">that</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal"> is of benefit to the nation. </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">There is a strong public expectation that national capacity should exist to enable proper surveillance of food and environment safety as well as disease monitoring and capacity to tackle conflict threats. </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">It is </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">worth</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal"> </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">recalling</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal"> </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">that the</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal"> Science and Technology Select C</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">ommittee concluded that the </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">Minister's logic around the value for money of closing the Forensic Science Survey in 2012 was ‘weak’</span><a name="_ftnref5"></a><a href="#_ftn5">[5]</a><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">. The Society of Biology would strongly recommended full consultation and analysis of</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal"> the implications any future changes to PSREs </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">to the</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal"> research environment, skills and expertise, and national economy.  </span></h1><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic; font-weight:bold">Future Inquiries</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">There are several lines of inquiry that the Select Committee may like to consider which would be beneficial to the UK </span><span style="font-family:'Times New Roman'; font-size:11pt">science R</span><span style="font-family:'Times New Roman'; font-size:11pt">&amp;</span><span style="font-family:'Times New Roman'; font-size:11pt">D sector. The Society of Biology suggests the following:</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span></p><ol type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; font-style:normal; line-height:115%; margin:0pt 0pt 10pt 31.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Directed Funding</span></li></ol><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Recently Government has increased capital funding though specific infrastructure announcements such as  the £50m for a National Graphene Institute, inv</span><span style="font-family:'Times New Roman'; font-size:11pt">estment in scientifi</span><span style="font-family:'Times New Roman'; font-size:11pt">c facilities, including The Francis Crick Institute and Pharmavision,  and £150 million of capital investment in 2015-16 to fund health research infrastructure in the areas of dementia, genomics and imaging. Funding is also promised for the ‘Great Eight’ t</span><span style="font-family:'Times New Roman'; font-size:11pt">echnologies for which analysis has suggested Government should be promoting with further capital investment and technology support</span><a name="_ftnref6"></a><a href="#_ftn6">[6]</a><span style="font-family:'Times New Roman'; font-size:11pt">. R&amp;D funding is welcome where it is needed and of most use, but does this shift toward directed funding conflict with the es</span><span style="font-family:'Times New Roman'; font-size:11pt">tablished Haldane Principle? The Chancellor stated in his 2013 Spending Review announcement: </span><span style="font-family:'Times New Roman'; font-size:11pt">‘</span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">Our philosophy is simple: trust people to make their own decisions and they will usually make better ones’</span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:normal">.</span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic"> </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:normal">What are the processes for deciding the allocation of </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:normal">capital funding? How should this best integrate with the Research Council’s remit and activities?</span></p><ol start="2" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; font-style:normal; line-height:115%; margin:0pt 0pt 10pt 31.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The Pharmaceutical Sector</span><a name="_ftnref7"></a><a href="#_ftn7">[7]</a></li></ol><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">The pharmaceutical </span><span style="font-family:'Times New Roman'; font-size:11pt">s</span><span style="font-family:'Times New Roman'; font-size:11pt">ector is a key driver for innovation in the UK, however o</span><span style="font-family:'Times New Roman'; font-size:11pt">ver recent years pharmaceutical R&amp;D within the UK has </span><span style="font-family:'Times New Roman'; font-size:11pt">undergone a significant transformation. An ecosystem of collaborative research partners is emerging which encompasses small and large pharma, SMEs, academia, health charities and the NHS, with each contributing complementary skills and expertise. Job losse</span><span style="font-family:'Times New Roman'; font-size:11pt">s at UK sites for GSK, AstraZeneca and Pfizer in recent years </span><span style="font-family:'Times New Roman'; font-size:11pt">cannot be ignored. What is the future for UK Pharma, and how can the Government ensure its continued success?</span></p><ol start="3" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; font-style:normal; line-height:115%; margin:0pt 0pt 10pt 31.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Research and Development Scoreboard</span></li></ol><p style="font-size:11pt; line-height:115%; margin:0pt 7.1pt 0pt 0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">The BIS R&amp;D Scoreboards were </span><span style="font-family:'Times New Roman'; font-size:11pt">discontinued in 2012 because of budgetary concerns. These scoreboards allowed for transparent, impartial and up to date evaluation of the level of R&amp;D activity in the UK, tracking of historical data trends and benchmarking of UK R&amp;D activity against other </span><span style="font-family:'Times New Roman'; font-size:11pt">nations. Given global fiscal uncertainty, we argue that this type of analysis firms up policy decision making, and </span><span style="font-family:'Times New Roman'; font-size:11pt">could help to inform and encourage </span><span style="font-family:'Times New Roman'; font-size:11pt"> investment in </span><span style="font-family:'Times New Roman'; font-size:11pt">the </span><span style="font-family:'Times New Roman'; font-size:11pt">UK by highlighting our strengths and allowing for closer inspection of where policies a</span><span style="font-family:'Times New Roman'; font-size:11pt">re, or are not working. How has the discontinuation affected the ability for Government and others to track policy and investment efficacy? Has this type of analysis been picked up elsewhere, and if so, </span><span style="font-family:'Times New Roman'; font-size:11pt">to what budgetary costs?</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span></p><p style="margin:0pt 7.1pt 0pt 0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt 7.1pt 0pt 0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt 7.1pt 0pt 0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">August 2013</span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">              </span></p></div><hr style="width:33%; height:1px; text-align:left" /><p style="margin:0pt"><a name="_ftn1"></a><a href="#_ftnref1">[1]</a><span style="font-family:Arial; font-size:10pt"> </span><span style="font-family:Arial; font-size:10pt">Department for Business Innovation and Skills </span><a href="http://www.rcuk.ac.uk/documents/documents/LeverageReport.pdf"><span style="color:#0000ff; font-family:Arial; font-size:10pt; text-decoration:underline">Leverage from public funding of science and research</span></a><span style="font-family:Arial; font-size:10pt">. Dr Sarah Main. June 2013</span></p><p style="margin:0pt"><a name="_ftn2"></a><a href="#_ftnref2">[2]</a><span style="font-family:Arial; font-size:10pt"> Chancellor George Osborne - 2013 Spending Review Ann</span><span style="font-family:Arial; font-size:10pt">ouncement </span></p><p style="margin:0pt"><a name="_ftn3"></a><a href="#_ftnref3">[3]</a><span style="font-family:Arial; font-size:10pt"> </span><span style="font-family:Arial; font-size:10pt">The Science Council </span><a href="http://www.google.com/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=web&amp;cd=1&amp;ved=0CCwQFjAA&amp;url=http%3A%2F%2Fwww.brighton.ac.uk%2Fcareers%2Findex.php%2Fdownload_file%2Fview%2F292%2F305%2F&amp;ei=PL8DUuzZCYn2O6CNgGg&amp;usg=AFQjCNGvEvvrZvJPYXoq_qY9jc-IIV_f0g&amp;sig2=x0xSfcf-MwI33Gk0omQlaw&amp;bvm=bv.50500085,d.ZWU&amp;cad=rja"><span style="color:#0000ff; font-family:Arial; font-size:10pt; text-decoration:underline">The current and future UK science workforce</span></a><span style="font-family:Arial; font-size:10pt"> September 2011.  </span></p><p style="margin:0pt"><span style="font-family:'Times New Roman'; font-size:10pt">&#xa0;</span></p><p style="margin:0pt"><a name="_ftn4"></a><a href="#_ftnref4">[4]</a><span style="font-family:Arial; font-size:10pt"> Department of Health – </span><a href="http://www.rcpsych.ac.uk/pdf/Structure%20of%20Public%20Health%20England.pdf"><span style="color:#0000ff; font-family:Arial; font-size:10pt; text-decoration:underline">Structure of Public Health England</span></a><span style="font-family:Arial; font-size:10pt">, July 2012</span></p><p style="margin:0pt"><a name="_ftn5"></a><a href="#_ftnref5">[5]</a><span style="font-family:Arial; font-size:10pt"> House of Commons Science ad Technology Select Committee. </span><a href="http://www.publications.parliament.uk/pa/cm201314/cmselect/cmsctech/610/61002.htm"><span style="color:#0000ff; font-family:Arial; font-size:10pt; text-decoration:underline">2nd Report - Forensic science -</span><span style="color:#0000ff; font-family:Arial; font-size:10pt; text-decoration:underline"> Volume I</span></a><span style="font-family:Arial; font-size:10pt"> . July 2013. </span></p><p style="margin:0pt"><a name="_ftn6"></a><a href="#_ftnref6">[6]</a><span style="font-family:Arial; font-size:10pt"> </span><a href="http://www.policyexchange.org.uk/images/publications/eight%20great%20technologies.pdf"><span style="color:#0000ff; font-family:Arial; font-size:10pt; text-decoration:underline">http://www.policyexchange.org.uk/images/publications/eight%20great%20technologies.pdf</span></a><span style="font-family:'Times New Roman'; font-size:10pt"> </span></p><p style="margin:0pt"><a name="_ftn7"></a><a href="#_ftnref7">[7]</a><span style="font-family:Arial; font-size:10pt"> </span><span style="font-family:Arial; font-size:10pt">The Society of Biology is a core mem</span><span style="font-family:Arial; font-size:10pt">ber of the </span><span style="font-family:Arial; font-size:10pt; font-weight:normal">Drug Discovery Pathways Group</span><span style="font-family:Arial; font-size:10pt">, an informal partnership that seeks to address these issues by </span><span style="font-family:Arial; font-size:10pt; font-weight:normal">establishing a networked community of skilled researchers to help revitalise the UK pharmaceutical sector. The group</span><span style="font-family:Arial; font-size:10pt; font-weight:bold"> </span><span style="font-family:Arial; font-size:10pt">focusses on three main areas;</span><span style="font-family:Arial; font-size:10pt; font-weight:bold"> </span><span style="font-family:Arial; font-size:10pt; font-weight:normal">industry-academia</span><span style="font-family:Arial; font-size:10pt; font-weight:bold"> </span><span style="font-family:Arial; font-size:10pt; font-weight:normal">partnerships</span><span style="font-family:Arial; font-size:10pt; font-weight:bold">, </span><span style="font-family:Arial; font-size:10pt; font-weight:normal">knowledge</span><span style="font-family:Arial; font-size:10pt; font-weight:bold"> </span><span style="font-family:Arial; font-size:10pt">and</span><span style="font-family:Arial; font-size:10pt; font-weight:bold"> </span><span style="font-family:Arial; font-size:10pt; font-weight:normal">skills, with around</span><span style="font-family:Arial; font-size:10pt; font-weight:bold"> </span><span style="font-family:Arial; font-size:10pt">20 learned societies and professional bodies involved in specific activities and work streams.</span><span style="font-family:'Times New Roman'; font-size:10pt"> </span><a href="https://www.societyofbiology.org/policy/policy-issues/biomedical-sciences/drug-discovery/drug-discovery-pathways-group"><span style="color:#0000ff; font-family:Arial; font-size:10pt; text-decoration:underline">https://www.societyofbiology.org/policy/policy-issues/biomedical-sciences/drug-discovery/drug-discovery-pathways-group</span></a></p></body></html>